GenMark to Sell 10 Million Shares in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – GenMark Diagnostics said after the close of the market on Tuesday that it intends to sell 10 million shares of its common stock in a public offering.

The Carlsbad, Calif.-based molecular diagnostics company did not price the offering or say how much in proceeds it anticipates raising. It said, though, that net proceeds will be used for R&D efforts to expand its menu and develop its NexGen System testing platform, as well as to expand its US and global commercial operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.